نتایج جستجو برای: her2 receptors

تعداد نتایج: 236775  

Journal: :Cancer research 2014
Cleo Yi-Fang Lee Yuan Lin Scott V Bratman Weiguo Feng Angera H Kuo Ferenc A Scheeren Jesse M Engreitz Sushama Varma Robert B West Maximilian Diehn

Currently, only patients with HER2-positive tumors are candidates for HER2-targeted therapies. However, recent clinical observations suggest that the survival of patients with HER2-low breast cancers, who lack HER2 amplification, may benefit from adjuvant therapy that targets HER2. In this study, we explored a mechanism through which these benefits may be obtained. Prompted by the hypothesis th...

Journal: :The Journal of biological chemistry 2001
F Jaulin-Bastard H Saito A Le Bivic V Ollendorff S Marchetto D Birnbaum J P Borg

Identification of protein complexes associated with the ERBB2/HER2 receptor may help unravel the mechanisms of its activation and regulation in normal and pathological situations. Interactions between ERBB2/HER2 and Src homology 2 or phosphotyrosine binding domain signaling proteins have been extensively studied. We have identified ERBIN and PICK1 as new binding partners for ERBB2/HER2 that ass...

Journal: :Oxidative medicine and cellular longevity 2016
Hilal S Khalil Simon P Langdon Ibrahim H Kankia James Bown Yusuf Y Deeni

NF-E2 related factor-2 (NRF2) is an essential transcription factor for multiple genes encoding antioxidants and detoxification enzymes. NRF2 is implicated in promoting cancer therapeutic resistance by its detoxification function and crosstalk with proproliferative pathways. However, the exact mechanism of this intricate connectivity between NRF2 and growth factor induced proliferative pathway r...

Journal: :Cancer research 2017
Kathleen C Day Guadalupe Lorenzatti Hiles Molly Kozminsky Scott J Dawsey Alyssa Paul Luke J Broses Rajal Shah Lakshmi P Kunja Christopher Hall Nallasivam Palanisamy Stephanie Daignault-Newton Layla El-Sawy Steven James Wilson Andrew Chou Kathleen Woods Ignatoski Evan Keller Dafydd Thomas Sunitha Nagrath Todd Morgan Mark L Day

Activation of the EGF receptors EGFR (ErbB1) and HER2 (ErbB2) drives the progression of multiple cancer types through complex mechanisms that are still not fully understood. In this study, we report that HER2 expression is elevated in bone metastases of prostate cancer independently of gene amplification. An examination of HER2 and NF-κB receptor (RANK) coexpression revealed increased levels of...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2012
Weidong Zhu Quynh T Phan Pinmanee Boontheung Norma V Solis Joseph A Loo Scott G Filler

The fungus Candida albicans is the major cause of oropharyngeal candidiasis (OPC). A key feature of this disease is fungal invasion of oral epithelial cells, a process that can occur by active penetration and fungal-induced endocytosis. Two invasins, Als3 and Ssa1, induce epithelial cell endocytosis of C. albicans, in part by binding to E-cadherin. However, inhibition of E-cadherin function onl...

2015
Paula González-Alonso Cristina Chamizo Víctor Moreno Juan Madoz-Gúrpide Nerea Carvajal Lina Daoud Sandra Zazo Ester Martín-Aparicio Ion Cristóbal Raúl Rincón Jesús García-Foncillas Federico Rojo William Chi-shing Cho

Mutations in Human Epidermal Growth Factor Receptors (HER) are associated with poor prognosis of several types of solid tumors. Although HER-mutation detection methods are currently available, such as Next-Generation Sequencing (NGS), alternative pyrosequencing allow the rapid characterization of specific mutations. We developed specific PCR-based pyrosequencing assays for identification of mos...

2009
Gajanan V. Sherbet

Growth factors and their receptor play a major part in normal growth and differentiation and also in tumour development and progression. Mutations or overexpression of growth factor receptors is associated with aggressive cancers and poor prognosis for patients. Growth factor receptors are transmembrane tyrosine kinase proteins that transduce growth factor signals imparted by their binding to s...

Journal: :Gynecologic oncology 2005
Christopher M Lee Dennis C Shrieve Karen A Zempolich R Jeffrey Lee Elizabeth Hammond Diana L Handrahan David K Gaffney

OBJECTIVE To investigate prognostic significance of and correlations between HER1 (EGFR), HER2 (c-erb-B2), HER3 (c-erb-B3), HER4 (c-erb-B4), and phosphorylated Akt (P-Akt) in patients treated with radiation for cervical carcinoma. METHODS Fifty-five patients with stages I-IVA cervical carcinoma were treated with definitive radiotherapy. Tumor expression of each biomarker was quantitatively sc...

Journal: :Beni-Suef University Journal of Basic and Applied Sciences 2023

Abstract Background CD155 is an immune checkpoint protein that interacts with ligands on natural killer cells to regulate the tumor associated immunity. overexpression has been detected in many human cancer types. and its pathways are promising immunotherapy targets. We aimed evaluate immunohistochemical expression of invasive breast carcinomas correlate such pathological parameters tumors also...

Journal: :Breast 2008
Zenonas Theodosiou Ioannis N Kasampalidis Georgia Karayannopoulou Ioannis Kostopoulos Mattheos Bobos Generoso Bevilacqua Paolo Aretini Antonina Starita Kleoniki Lyroudia Ioannis Pitas

HER2-positive breast cancer is characterized by aggressive growth and poor prognosis. Women with metastatic breast cancer with over-expression of HER2 protein or excessive presence of HER2 gene copies are potential candidates for Herceptin (Trastuzumab) targeted treatment that binds to HER2 receptors on tumor cells and inhibits tumor cell growth. Fluorescence in situ hybridization (FISH) is one...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید